Non-myeloablative allogeneic stem cell transplant: Achievements and perspectives

Keyphrases

• Nonmyeloablative 100%
• Non-myeloablative Transplantation 100%
• Immunosuppression 66%
• Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) 66%
• Engraftment 66%
• Myeloablation 66%
• Clinical Experience 33%
• Old Age 33%
• T Cells 33%
• Conditioning Regimen 33%
• Graft-versus-leukemia Effect 33%
• Treatment Toxicity 33%
• Transplant Center 33%
• Clinical Development 33%
• Organ Dysfunction 33%
• Tumor Effect 33%
• Stem Cell Transplantation 33%
• Donor-derived 33%

Medicine and Dentistry

• Stem Cell Transplant 100%
• Nonmyeloablative Stem Cell Transplantation 100%
• Immunosuppressive Treatment 66%
• Engraftment 66%
• Allogeneic Hematopoietic Stem Cell Transplantation 66%
• Neoplasm 33%
• T Cell 33%
• Graft Versus Leukemia Effect 33%
• Stem Cell Therapy 33%
• Organ Dysfunction 33%

Immunology and Microbiology

• Nonmyeloablative Stem Cell Transplantation 100%
• Stem Cell Transplant 100%
• Immunosuppression 66%
• Engraftment 66%
• Allogeneic Hematopoietic Stem Cell Transplantation 66%
• T Cell 33%
• Stem Cell Transplantation 33%